Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 5078 results
Pharmalink raises funds to advance Nefecon development to treat kidney disease
By PBR Staff Writer
Pharmalink has raised SEK100m (€10.5m) to advance the development of Nefecon as a new treatment for kidney disease.
Drug Research > Drug Discovery & Development > News
Neon Therapeutics secures $55m to develop neoantigen-based cancer immunotherapies
By PBR Staff Writer
Immuno-oncology firm Neon Therapeutics has secured $55m in initial funding to develop neoantigen-based cancer immunotherapies.
Drug Research > Drug Discovery & Development > News
Biohaven and FCCDC form alliance in early stage drug discovery research
Portage Biotech and Biohaven Pharmaceutical have formed a strategic alliance with ALS Biopharma and Fox Chase Chemical Diversity Center (FCCDC) to develop Biohaven's family of over 300 prodrugs of glutamate modulating agents as well as other innovative technologies.
Drug Research > Drug Discovery & Development > News
Daiichi Sankyo expands TaNeDS collaborative drug discovery program in Europe
Daiichi Sankyo Company announced details of the application for its Take a New Challenge for Drug Discovery (TaNeDS) Europe 2015/2016, a collaborative drug discovery initiative for universities and research institutes in Europe.
Drug Research > Drug Discovery & Development > News
Genzyme opts into Alnylam's ALN-AT3 hemophilia program
By PBR Staff Writer
Genzyme has joined in Alnylam Pharmaceuticals' investigational ALN-AT3 hemophilia program for development and commercialization in territories outside of North America and Western Europe.
Drug Research > Drug Discovery & Development > News
EMA releases draft guideline for public consultation to accelerate antibiotics development
The European Medicines Agency (EMA) has released a draft guideline for public consultation on the use of pharmacokinetics and pharmacodynamics analyses in the development of antibiotics.
Drug Research > Drug Discovery & Development > News
Accelerator secures $11.7m in new investment commitments
Accelerator Corporation has secured an additional $11.7m in new investment commitments, bringing the final Accelerator IV closing to an oversubscribed $62.8m.
Drug Research > Drug Discovery & Development > News
Commercial Services
Through its Pharma Services Business Unit Almac provides commercial manufacturing and packaging of solid dosage forms in addition to commercial support services and 3PL (third party logistics) which incorporates the management of ordering, financial and distribution. In addition, it offers significant expertise managing the supply and distribution of product into the EU marketplace on behalf of US based companies.
Drug Research > Drug Discovery & Development > Products
Clinical Technologies
Almac specialises in technology and professional services that minimise clinical trial processes and legacy workflows while maximising staff productivity. Offerings include the industry's most configurable interactive voice and web response system (IXRS®) for patient randomisation and inventory management; phone and web-based patient diaries (ePRO), and expert statistical and data integration consulting.
Drug Research > Drug Discovery & Development > Products
Clinical Services
Almac designs and provides blinding, packaging and logistics services for global clinical trials, incorporating leading technologies and efficient solutions through the most experienced supply chain management in the marketplace.
Drug Research > Drug Discovery & Development > Products
Pharmaceutical Development
Operating from state-of-the-art, custom-designed facilities, Almac develops clinical candidates into an optimum formulation, and manufactures drug product for all phases of clinical trial supply (Phase 0 – Phase IV). In-house engineered containment solutions also allow for the development and manufacture of highly potent products.
Drug Research > Drug Discovery & Development > Products
API Services & Chemical Development
Almac specialises in chemical development, API supply (both small molecules and peptides) and biocatalysis technology. Based in both the UK and US with state-of-the-art facilities it also offers a “First In Human” program - rapidd™, a lean, efficient, integrated package from selection of pre-clinical candidate to Phase I regulatory submission.
Drug Research > Drug Discovery & Development > Products
Diagnostics & Biomarker Discovery
Almac is uniquely placed to lead clients through the entire process of companion diagnostic development. Its Diagnostics’ Business Unit provides solutions ranging from pre-clinical biomarker discovery, through to full companion diagnostic development.
Drug Research > Drug Discovery & Development > Products
Almac Group’s Integrated CMC Services Support US Approval of Wellstat Therapeutics’ First Commercial Orphan Drug Product
Almac Group, the global contract development and manufacturing organisation, wishes to congratulate its long term client partner Wellstat Therapeutics on the commercial approval of their first orphan drug product XURIDEN™ (uridine triacetate). XURIDEN has been developed as a treatment for the rare disease Hereditary Orotic Aciduria (HOA).
Drug Research > Drug Discovery & Development > Press Releases
Almac Group expands Asia Pacific Presence with New Regional Headquarters and Clinical Trial Supply Facility in Singapore
Due to the overwhelming success experienced since the launch of its “Direct to Patient” shipping service for clinical trials throughout US and Canada in October last year, Almac has announced the expansion of this innovative service to EU countries.
Drug Research > Drug Discovery & Development > Press Releases

PBR Supplier Recommendations

Therapure Biopharma - Contract Protein Development and Manufacturing
Therapure Biopharma is a Contract Development and Manufacturing Organization (CDMO) that specializes in the development, scale up and manufacture of complex biologics. ... Drug Research > Drug Discovery & Development > Suppliers
Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Discovery & Development > Suppliers
ERT - Getting it done. Right.
ERT is a leading global provider of high-quality patient safety and efficacy endpoint data collection solutions for use by biopharmaceutical companies during clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle.... Drug Research > Drug Discovery & Development > Suppliers
Eppendorf - We Know Bioprocessing
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO² incubators, shakers, and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates, and disposable bioreactors complement the range of highest-quality premium products.... Drug Research > Drug Discovery & Development > Suppliers
Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

Sciences Radiolabelling Brochure By Almac
Trust Almac with your 14C radiolabelling requirements and we will offer advice on the most appropriate label position for your molecule, including synthetic feasibility and metabolic stability.... Drug Research > Drug Discovery & Development > White Papers Commerical Packaging By Almac
- Complementary US and UK operations, - Quality-driven, flexible packaging solutions, - Market leader for product launch of niche / orphan drug products, - Solid oral dose and biopharmaceutical packaging, - Packaging and artwork design, - Full serialisation and 2D matrix barcoding solutions.... Drug Research > Drug Discovery & Development > White Papers Providing an Unparalleled Range of Contract Pharmaceutical Development and Manufacturing Services Globally for Over 40 Years By Almac
Only we can combine the expertise from our range of specialised services to provide you with the right solutions to help you develop and commercialise your products.... Drug Research > Drug Discovery & Development > White Papers Building the Next Generation IRT: An Exclusive Look Under the Hood of IXRS®3 By Almac
Interactive Response Technology (IRT) systems - used to manage patient interactions and drug supplies during clinical trials - perform a range of functions for sponsors, drug depots, and investigative sites. Yet, they are typically viewed by sponsors as a "painful necessity" rather than as a welcome, invaluable tool. That perception exists because the underlying technology is outmoded, and the user's experience is stuck in the pre-Internet era. While established systems are "tried and true" in that they have supported thousands of clinical trials over the years, they can also be tired and cumbersome.... Drug Research > Drug Discovery & Development > White Papers Introducing Direct to Patient Shipments By Almac
Almac will ship the Clinical Trial Material (CTM) to participating clinical sites, where the drug is to be stored. Both shipping and storage of the CTM will follow standard procedures. Sites will interact with the Interactive Response Technology (IRT) provider in the usual way to obtain a kit assignment.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 5078 results